Found 15 matching trials
Docetaxel Plus Plinabulin vs Docetaxel Plus Placebo in Advanced/Metastatic Non-Squamous NSCLC After PD-1/PD-L1 Therapy and Platinum Chemotherapy (DUBLIN-4) PHASE3 This is a global, multicenter, randomized, double-blind, placebo-controlled...
Show More Location
Multiple Locations
Learn More & Join Trial
Nivolumab and Plinabulin in Treating Patients With Stage IIIB-IV, Recurrent, or Metastatic Non-small Cell Lung Cancer PHASE1 This phase I/II trial studies the side effects and best dose of plinabulin ...
Show More Location
Fred Hutch/University of Washington Cancer Consortium
Learn More & Join Trial
A Phase I/II Study of Nivolumab, Ipilimumab and Plinabulin in Patients With Recurrent Small Cell Lung Cancer PHASE1 This is an open-label Phase I/II study, with a dose escalation part (Phase ...
Show More Learn More & Join Trial
Plinabulin in Combination With Radiation/Immunotherapy in Patients With Select Advanced Cancers After Progression on PD-1 or PD-L1 Targeted Antibodies PHASE1 This phase Ib/II trial studies the side effects and best dose of plinabulin...
Show More Location
M D Anderson Cancer Center
Learn More & Join Trial
Plinabulin iv Solution in Prevention of TAC Induced Neutropenia PHASE2 The primary purpose of this study is to compare the duration of severe neut...
Show More Location
Cancer Center of Guangzhou Medical University Breast Oncology
Learn More & Join Trial
Pembrolizumab in Combination With Plinabulin and Docetaxel For Metastatic NSCLC After ICIs (KeyPemls-004) PHASE2 A Phase 2 Study of Pembrolizumab in Combination with Plinabulin and Docetax...
Show More Status
Active Not Recruiting
Location
Department of Respiratory and Critical Care Medicine, Peking Union Medical College Hospital
Learn More & Join Trial
Plinabulin vs. Pegfilgrastim in Prevention of TAC Induced Neutropenia PHASE3 The primary purpose of this study is to compare the percentage of patients ...
Show More Location
No. 1 Banshandong Road
Learn More & Join Trial
Study of Plinabulin and Pegfilgrastim in People With Multiple Myeloma Undergoing an Autologous Hematopoietic Stem Cell Transplant (AHCT) PHASE2 This study will see how long it takes for white blood cell counts to return...
Show More Status
Active Not Recruiting
Location
Memorial Sloan Kettering Basking Ridge (Limited Protocol Activities)
Learn More & Join Trial
Study of the Vascular Disrupting Agent NPI-2358 in Patients With Advanced Solid Tumors or Lymphoma PHASE1 This is a Phase 1 clinical trial examining the safety, pharmacokinetics and...
Show More Location
Barbara Ann Karmanos Cancer Institute/Wayne State University
Learn More & Join Trial
First Line Pembrolizumab, Plinabulin Plus Etoposide and Platinum (EP) for ES-SCLC PHASE2 Monoclonal antibodies against programmed death 1 (PD-1) and its ligand PD-L...
Show More Learn More & Join Trial